Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

α‐synuclein And NotJ. P. Larsen

List of bibliographic references

Number of relevant bibliographic references: 34.
Ident.Authors (with country if any)Title
000105 S. Orimo [Japon] ; T. Uchihara [Japon] ; T. Kanazawa [Japon] ; Y. Itoh [Japon] ; K. Wakabayashi ; A. Kakita [Japon] ; H. Takahashi [Japon]Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease
000207 Michael J. Devine [Royaume-Uni] ; Katrina Gwinn [États-Unis] ; Andrew Singleton [États-Unis] ; John Hardy [Royaume-Uni]Parkinson's disease and α‐synuclein expression
000253 Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis]Milestones in Parkinson's disease—Clinical and pathologic features
000303 Glenda M. Halliday [Australie] ; Claire H. Stevens [Australie]Glia: Initiators and progressors of pathology in Parkinson's disease
000512 Glenda Margaret Halliday [Australie] ; Heather Mccann [Australie]The progression of pathology in Parkinson's disease
000585 Raquel Duran [Espagne] ; Francisco J. Barrero [Espagne] ; Blas Morales [Espagne] ; Juan D. Luna [Espagne] ; Manuel Ramirez [Espagne] ; Francisco Vives [Espagne]Plasma α‐synuclein in patients with Parkinson's disease with and without treatment
000659 Yaping Chu [États-Unis] ; Jeffrey H. Kordower [États-Unis]Lewy body pathology in fetal grafts
000781 Jia-Yi Li [Suède] ; Elisabet Englund [Suède] ; H Kan Widner [Suède] ; Stig Rehncrona [Suède] ; Anders Björklund [Suède] ; Olle Lindvall [Suède] ; Patrik Brundin [Suède]Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
000931 Thibaud Lebouvier [France] ; Tanguy Chaumette [France] ; Sébastien Paillusson [France] ; Charles Duyckaerts [France] ; Stanislas Bruley Des Varannes [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France]The second brain and Parkinson’s disease
000A88 Christian Wider [États-Unis] ; Justus C. Dachsel [États-Unis] ; Alexandra I. Soto [États-Unis] ; Michael G. Heckman [États-Unis] ; Nancy N. Diehl [États-Unis] ; Mei Yue [États-Unis] ; Sarah Lincoln [États-Unis] ; Jan O. Aasly [Norvège] ; Kristoffer Haugarvoll [États-Unis, Norvège] ; John Q. Trojanowski [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Deborah Mash [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; J. Mark Gibson [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Dennis W. Dickson [États-Unis] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [États-Unis] ; Owen A. Ross [États-Unis]FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression
000C47 M. E. Kalaitzakis [Royaume-Uni] ; M. B. Graeber [Royaume-Uni] ; S. M. Gentleman [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni]The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging
000D50 Ji-Young Park [Corée du Sud] ; Seung R. Paik [Corée du Sud] ; Ilo Jou [Corée du Sud] ; Sang Myun Park [Corée du Sud]Microglial phagocytosis is enhanced by monomeric α‐synuclein, not aggregated α‐synuclein: Implications for Parkinson's disease
000D87 Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]Glial reactions in Parkinson's disease
000E15 Masaki Wakamatsu [Japon] ; Shingo Iwata [Japon] ; Takeo Funakoshi [Japon] ; Makoto Yoshimoto [Japon]Dopamine receptor agonists reverse behavioral abnormalities of α‐synuclein transgenic mouse, a new model of Parkinson's disease
000E51 Hiroshige Fujishiro [États-Unis] ; Roberta Frigerio [États-Unis] ; Melinda Burnett [États-Unis] ; Kevin J. Klos [États-Unis] ; Keith A. Josephs [États-Unis] ; Anthony Delledonne [États-Unis] ; Joseph E. Parisi [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Dennis W. Dickson [États-Unis]Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease
000F34 C. Warren Olanow [États-Unis]The pathogenesis of cell death in Parkinson's disease – 2007
000F40 Koichi Wakabayashi ; Kunikazu Tanji ; Fumiaki Mori ; Hitoshi Takahashi [Japon]The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
000F46 Takeshi Iwatsubo [Japon]THIS ARTICLE HAS BEEN RETRACTED: Pathological biochemistry of α‐synucleinopathy
001026 Osamu Yokota ; Kuniaki Tsuchiya ; Toshiki Uchihara ; Hiroshi Ujike ; Seishi Terada ; Mafuyu Takahashi ; Yuji Kimura ; Hideki Ishizu [Japon] ; Haruhiko Akiyama ; Shigetoshi KurodaLewy body variant of Alzheimer’s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem
001048 Anna Jelaso Langerveld [États-Unis] ; Daniel Mihalko [États-Unis] ; Cari Delong [États-Unis] ; Jeff Walburn [États-Unis] ; Charles F. Ide [États-Unis]Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients
001128 Masaki Wakamatsu [Japon] ; Aiko Ishii [Japon] ; Yuriko Ukai [Japon] ; Junko Sakagami [Japon] ; Shingo Iwata [Japon] ; Mieko Ono [Japon] ; Kayo Matsumoto [Japon] ; Atsushi Nakamura [Japon] ; Norihiro Tada [Japon] ; Kazuto Kobayashi [Japon] ; Takeshi Iwatsubo [Japon] ; Makoto Yoshimoto [Japon]Accumulation of phosphorylated α‐synuclein in dopaminergic neurons of transgenic mice that express human α‐synuclein
001158 A. Bloch [Suisse] ; A. Probst [Suisse] ; H. Bissig [Suisse] ; H. Adams [Suisse] ; M. Tolnay [Suisse]α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
001198 Heiko Braak [Allemagne] ; Jürgen R. Bohl [Allemagne] ; Christian M. Müller [Allemagne] ; Udo Rüb [Allemagne] ; Rob A. I. De Vos [Pays-Bas] ; Kelly Del Tredici [Allemagne]Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered
001388 Laura Parkkinen [Finlande] ; Tuula Pirttil [Finlande] ; Markku Tervahauta [Finlande] ; Irina Alafuzoff [Finlande]Widespread and abundant α‐synuclein pathology in a neurologically unimpaired subject
001490 Silvia Mandel [Israël] ; Edna Grunblatt [Allemagne] ; Peter Riederer [Allemagne] ; Ninette Amariglio [Israël] ; Jasmine Jacob Hirsch [Israël] ; Gideon Rechavi [Israël] ; Moussa B. H. Youdim [Israël]Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70
001701 Kah Leong Lim ; Valina L. Dawson [États-Unis] ; Ted M. Dawson [États-Unis]The Cast of Molecular Characters in Parkinson's Disease
001761 Hideo Mori [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]Genotype–phenotype correlation: Familial Parkinson disease
001849 Eliezer Masliah [États-Unis] ; Lawrence A. Hansen [États-Unis] ; Edward Rockenstein [États-Unis] ; Makoto Hashimoto [États-Unis]Progress in the development of new treatments for combined Alzheimer's and Parkinson's diseases
001880 David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada]Large French‐Canadian family with Lewy body parkinsonism: Exclusion of known loci
001942 Kevin St P. Mcnaught [États-Unis] ; P. Shashidharan [États-Unis] ; Daniel P. Perl [États-Unis] ; Peter Jenner [Royaume-Uni] ; C. Warren Olanow [États-Unis]Aggresome‐related biogenesis of Lewy bodies
001A08 Hitoshi Takahashi ; Koichi Wakabayashi [Japon]The cellular pathology of Parkinson's disease
001A61 Nadia Stefanova [Autriche, Bulgarie] ; Lars Klimaschewski [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; Markus Reindl [Autriche]Glial cell death induced by overexpression of α‐synuclein
001A95 S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; A. Papadimitriou [Grèce] ; V. Veletza [Grèce] ; G. Hatzigeorgiou [Grèce] ; A. Lees [Royaume-Uni]Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation
001B98 John E. Duda [États-Unis] ; Virginia M. Lee [États-Unis] ; John Q. Trojanowski [États-Unis]Neuropathology of synuclein aggregates
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024